SILO PHARMA, INC. Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate
SILO PHARMA, INC. (SILO) reported Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate of 158.60% for the 12-month period ending 2019-12-31, per its 10-K/A filed 2021-05-17.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate · last filed 2021-05-17
- SILO PHARMA, INC. share-based goods and nonemployee services transaction, valuation method, expected volatility rate for fiscal 2019 was 158.60%.
| Period end | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 12 month |
|---|---|
| 2019-12-31 | 158.60% 10-K/A · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |